NYSE : PHG
Koninklijke Philips N.V. — Key statistics
Healthcare · Medical Devices · Netherlands
Last price 27.12 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 26.50B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 26.45B |
| Enterprise Value | 32.82B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | May 13, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | n/a |
| Shares Outstanding | 977.43M |
| Shares Change (YoY) | +3.68% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 60.02% |
| Float | 976.81M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 21.10 |
| Forward PE | 15.01 |
| PS Ratio | 1.31 |
| Forward PS | 1.32 |
| PB Ratio | 2.02 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 11.88 |
| P/OCF Ratio | 10.38 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 25.79 |
| EV / Sales | 1.63 |
| EV / EBITDA | 11.89 |
| EV / EBIT | 16.63 |
| EV / FCF | 14.74 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.26 |
| Quick Ratio | 0.73 |
| Debt / Equity | 0.65 |
| Debt / EBITDA | 2.86 |
| Debt / FCF | 3.83 |
| Interest Coverage | 6.08 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 10.15% |
| Return on Assets (ROA) | 4.07% |
| Return on Invested Capital (ROIC) | 7.65% |
| Return on Capital Employed (ROCE) | 8.96% |
| Weighted Average Cost of Capital (WACC) | 7.75% |
| Revenue Per Employee | $316,973 |
| Profits Per Employee | $19,989 |
| Employee Count | 63,670 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 2.96 |
Taxes
| Measure | Value |
|---|
| Income Tax | 414.71M |
| Effective Tax Rate | 24.63% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.92 |
| 52-Week Price Change | -2.46% |
| 50-Day Moving Average | 25.52 |
| 200-Day Moving Average | 27.21 |
| Relative Strength Index (RSI) | 65.39 |
| Average Volume (20 Days) | 1,343,878 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2.79M |
| Short Previous Month | 2.60M |
| Short % of Shares Out | 0.12% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.52 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 20.18B |
| Gross Profit | 9.27B |
| Operating Income | 1.97B |
| Pretax Income | 1.68B |
| Net Income | 1.27B |
| EBITDA | 2.76B |
| EBIT | 1.97B |
| Earnings Per Share (EPS) | $1.28 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 2.04B |
| Total Debt | 8.53B |
| Net Cash | -6.48B |
| Net Cash Per Share | -$6.63 |
| Equity (Book Value) | 13.11B |
| Book Value Per Share | 13.38 |
| Working Capital | 2.18B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 2.55B |
| Capital Expenditures | -321.62M |
| Depreciation & Amortization | 768.30M |
| Net Borrowing | -1.31B |
| Free Cash Flow | 2.23B |
| FCF Per Share | $2.28 |
Margins
| Measure | Value |
|---|
| Gross Margin | 45.94% |
| Operating Margin | 9.78% |
| Pretax Margin | 8.34% |
| Profit Margin | 6.31% |
| EBITDA Margin | 13.68% |
| EBIT Margin | 9.78% |
| FCF Margin | 11.29% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $0.84 |
| Dividend Yield | 3.13% |
| Dividend Growth (YoY) | 2.35% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 66.18% |
| FCF Payout Ratio | 37.07% |
| Buyback Yield | -3.68% |
| Shareholder Yield | -0.56% |
| Earnings Yield | 4.74% |
| FCF Yield | 8.42% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $32.02 |
| Price Target Difference | 18.95% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 3.19% |
| EPS Growth Forecast (3Y) | 6.72% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | May 9, 2024 |
| Split Type | Forward |
| Split Ratio | 1.03416654:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.02 |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |